Revolutionary Test for Detecting Drug-Induced Liver Injury Unveiled by C-Path’s Predictive Safety Testing Consortium
The Rise of Glutamate Dehydrogenase as a Liver-Specific Biomarker in Drug Development In the realm of drug development and clinical diagnostics, the search for more...












![PET protein atlases for various [11C]MC1 positron PET imaging metrics targeting COX-2.](https://bioengineer.org/wp-content/uploads/2025/03/Breakthrough-PET-Radiotracer-Offers-Initial-Insights-into-Brain-Inflammation-Biomarkers-350x250.jpeg)


